Cargando…

Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis

Introduction: E. faecium and E. faecalis are responsible for 13.9% of hospital-acquired infections with frequent resistance to vancomycin (82.6% of E. faecium, 9.5% of E. faecalis). Medical device infections secondary to enterococci often require combination therapy due to impaired activity against...

Descripción completa

Detalles Bibliográficos
Autores principales: Barber, Katie E., Shammout, Zade, Smith, Jordan R., Kebriaei, Razieh, Morrisette, Taylor, Rybak, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388763/
https://www.ncbi.nlm.nih.gov/pubmed/34438947
http://dx.doi.org/10.3390/antibiotics10080897
_version_ 1783742711695671296
author Barber, Katie E.
Shammout, Zade
Smith, Jordan R.
Kebriaei, Razieh
Morrisette, Taylor
Rybak, Michael J.
author_facet Barber, Katie E.
Shammout, Zade
Smith, Jordan R.
Kebriaei, Razieh
Morrisette, Taylor
Rybak, Michael J.
author_sort Barber, Katie E.
collection PubMed
description Introduction: E. faecium and E. faecalis are responsible for 13.9% of hospital-acquired infections with frequent resistance to vancomycin (82.6% of E. faecium, 9.5% of E. faecalis). Medical device infections secondary to enterococci often require combination therapy due to impaired activity against biofilm embedded cells. In vitro data demonstrate synergistic activity of daptomycin combinations. Using a novel, biofilm time-kill approach, we evaluated whether daptomycin combinations maintained synergy against biofilm-producing E. faecium and E. faecalis. Methods: Broth microdilution (BMD) and biofilm MIC (bMIC) values for daptomycin, ampicillin, ceftriaxone, fosfomycin, and rifampin were determined against biofilm-producing E. faecium and E. faecalis. Daptomycin combination bMIC values were determined in the presence of biologic concentrations of other antimicrobials. Synergy was evaluated against two E. faecalis (R6981, R7808) and two E. faecium (5938 and 8019) using a previously described biofilm time-kill method. Synergy was defined as ≥2 log10 CFU/cm(2) reduction over the most active agent alone. Bactericidal activity was defined as ≥3 log10 CFU/cm(2) reduction. Results: Daptomycin bMICs were 2–8-fold higher than BMD. In the presence of other antimicrobials, daptomycin bMICs were reduced ≥ two-fold in dilutions. Ceftriaxone and ampicillin demonstrated the most potent combinations with daptomycin, yielding synergy against three of four strains. Daptomycin plus rifampin was synergistic against E. faecium 5938 and E. faecalis 6981 and produced bactericidal kill. The combination of daptomycin plus fosfomycin displayed synergy solely against E. faecalis 6981. Conclusions: Daptomycin combinations with beta-lactams demonstrated promising synergistic activity against both E. faecium and E. faecalis. While daptomycin plus rifampin yielded bactericidal results, the effect was not seen across all organisms. These combinations warrant further evaluation to determine the optimal dose and response.
format Online
Article
Text
id pubmed-8388763
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83887632021-08-27 Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis Barber, Katie E. Shammout, Zade Smith, Jordan R. Kebriaei, Razieh Morrisette, Taylor Rybak, Michael J. Antibiotics (Basel) Article Introduction: E. faecium and E. faecalis are responsible for 13.9% of hospital-acquired infections with frequent resistance to vancomycin (82.6% of E. faecium, 9.5% of E. faecalis). Medical device infections secondary to enterococci often require combination therapy due to impaired activity against biofilm embedded cells. In vitro data demonstrate synergistic activity of daptomycin combinations. Using a novel, biofilm time-kill approach, we evaluated whether daptomycin combinations maintained synergy against biofilm-producing E. faecium and E. faecalis. Methods: Broth microdilution (BMD) and biofilm MIC (bMIC) values for daptomycin, ampicillin, ceftriaxone, fosfomycin, and rifampin were determined against biofilm-producing E. faecium and E. faecalis. Daptomycin combination bMIC values were determined in the presence of biologic concentrations of other antimicrobials. Synergy was evaluated against two E. faecalis (R6981, R7808) and two E. faecium (5938 and 8019) using a previously described biofilm time-kill method. Synergy was defined as ≥2 log10 CFU/cm(2) reduction over the most active agent alone. Bactericidal activity was defined as ≥3 log10 CFU/cm(2) reduction. Results: Daptomycin bMICs were 2–8-fold higher than BMD. In the presence of other antimicrobials, daptomycin bMICs were reduced ≥ two-fold in dilutions. Ceftriaxone and ampicillin demonstrated the most potent combinations with daptomycin, yielding synergy against three of four strains. Daptomycin plus rifampin was synergistic against E. faecium 5938 and E. faecalis 6981 and produced bactericidal kill. The combination of daptomycin plus fosfomycin displayed synergy solely against E. faecalis 6981. Conclusions: Daptomycin combinations with beta-lactams demonstrated promising synergistic activity against both E. faecium and E. faecalis. While daptomycin plus rifampin yielded bactericidal results, the effect was not seen across all organisms. These combinations warrant further evaluation to determine the optimal dose and response. MDPI 2021-07-23 /pmc/articles/PMC8388763/ /pubmed/34438947 http://dx.doi.org/10.3390/antibiotics10080897 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Barber, Katie E.
Shammout, Zade
Smith, Jordan R.
Kebriaei, Razieh
Morrisette, Taylor
Rybak, Michael J.
Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis
title Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis
title_full Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis
title_fullStr Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis
title_full_unstemmed Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis
title_short Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis
title_sort biofilm time-kill curves to assess the bactericidal activity of daptomycin combinations against biofilm-producing vancomycin-resistant enterococcus faecium and faecalis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388763/
https://www.ncbi.nlm.nih.gov/pubmed/34438947
http://dx.doi.org/10.3390/antibiotics10080897
work_keys_str_mv AT barberkatiee biofilmtimekillcurvestoassessthebactericidalactivityofdaptomycincombinationsagainstbiofilmproducingvancomycinresistantenterococcusfaeciumandfaecalis
AT shammoutzade biofilmtimekillcurvestoassessthebactericidalactivityofdaptomycincombinationsagainstbiofilmproducingvancomycinresistantenterococcusfaeciumandfaecalis
AT smithjordanr biofilmtimekillcurvestoassessthebactericidalactivityofdaptomycincombinationsagainstbiofilmproducingvancomycinresistantenterococcusfaeciumandfaecalis
AT kebriaeirazieh biofilmtimekillcurvestoassessthebactericidalactivityofdaptomycincombinationsagainstbiofilmproducingvancomycinresistantenterococcusfaeciumandfaecalis
AT morrisettetaylor biofilmtimekillcurvestoassessthebactericidalactivityofdaptomycincombinationsagainstbiofilmproducingvancomycinresistantenterococcusfaeciumandfaecalis
AT rybakmichaelj biofilmtimekillcurvestoassessthebactericidalactivityofdaptomycincombinationsagainstbiofilmproducingvancomycinresistantenterococcusfaeciumandfaecalis